Found 2381 clinical trials
BAY-94-8862/16244 - A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
- 1061 views
- 25 Mar, 2021
- 1 location
Immunocompromised Covid-19 Treatment and Prevention Study C1200
Is your child diabetic, obese, asthmatic, or Immunocompromised, and under the age of 18? They can participate in a clinical study with an approved Covid-19 treatment for adults. Immunocompromised Covid-19 Treatment and Prevention Study.
- 0 views
- 29 Dec, 2022
- 1 location
Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.
Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.
- 248 views
- 08 Nov, 2020
- 1 location
The INSTRIDE 2 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 2 Diabetes.
The INSTRIDE 2 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 2 Diabetes.
- 207 views
- 23 Nov, 2020
- 1 location
The INSTRIDE 1 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes.
The INSTRIDE 1 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes.
- 459 views
- 23 Nov, 2020
- 1 location
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
- 303 views
- 08 Nov, 2020
- 1 location
If you are at least 18 years of age, have been diagnosed and currently treating for type 2 diabetes, please contact Coastal Carolina Research Center about our new medical research study.
If you are at least 18 years of age, have been diagnosed and currently treating for type 2 diabetes, please contact Coastal Carolina Research Center about our new medical research study.
- 193 views
- 25 Mar, 2021
- 1 location
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse
- 342 views
- 08 Nov, 2020
- 1 location
DECLARE -Dapagliflozin Effect on CardiovascuLAR Events - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
- 170 views
- 25 Mar, 2021
- 1 location
![A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deuterated [d6] -dextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type](/media/imagery/143333.svg)
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deuterated [d6] -dextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type
A Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deuterated [d6] -dextromethorphan hydrobromide [d6-DM
- 150 views
- 25 Mar, 2021
- 1 location